The ‘Role of BRCA1 in DNA Damage Response’ was predicted to be the most significantly activated canonical pathway (p = 1.86E-04), which suggests a baseline intrinsic resistance of non-responding cervical cancer tumors. Here, BRCA1 is linked to cervical cancer.